EGFR-mutant lung adenocarcinoma transformed into small cell Lung cancer: A case report and literatures review

Advances in molecular biology have positioned epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) as highly effective therapies for patients with EGFR-mutant carcinomas. However, the inevitable emergence of acquired resistance significantly limits their long-term efficacy. Among...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Jinhong Chen, Hongxiang Huang, Peiyuan Zhong, Sujuan Peng, Xie Zhu, Xinjing Ding, Fen Wang, Ping Kong, Tiantian Song, Zhihui Lu, Li Chen
Format: Artigo
Jezik:Inglês
Izdano: Elsevier 2025-01-01
Serija:Respiratory Medicine Case Reports
Teme:
Small cell lung cancer
Lung adenocarcinoma
Transformation
EGFR mutation
Repeat biopsy
Online pristup:http://www.sciencedirect.com/science/article/pii/S2213007125000553
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items